The neuroendocrine tumours treatment market was valued at USD 2.45 Billion in 2024 and is expected to grow at a CAGR of 8.23% from 2025 to 2034, reaching USD 5.40 Billion by 2034. This growth is driven by rising incidence rates and advancements in treatment modalities across the 8 major markets. The report covers key trends, drivers, and market insights. https://www.expertmarketresearch.com/reports/neuroendocrine-tumours-treatment-market